Coluracetam (MKC-231)

• Product NameColuracetam (MKC-231)
  CAS No.135463-81-9
  Purity99%
  Min Quantity1Kilograms
  Price1~10
• View Contact Detail

• 
  Molecular Structure

Detailed Description

Coluracetam is a nootropic drug of the racetam family. Coluracetam was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California.

Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD). BrainCells Inc is currently out-licensing the drug for this purpose. It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury.

Web: www.rawsgear.com
Web: www.rawsgearpharma.com
Email: gear@quality-steroid.com
Skype: +8615711952876
Whatsapp +8615711952876